This article is definitely republished with kind permission from our friends at the The Kaiser Family members Foundation. You will see the entire Kaiser Daily Health Plan Statement, search the archives, or sign up for email delivery of in-depth coverage of wellness policy developments, debates and discussions. The Kaiser Daily Wellness Policy Report is released for Kaisernetwork.org, a free of charge program of The Henry J. Kaiser Family Foundation. Copyright 2006 Advisory Board Kaiser and Company Family Foundation.University of Michigan sufferers in whom GVHD developed were older and much more likely to have received HLA-mismatched or unrelated-donor transplants than individuals without GVHD. Patients receiving methotrexate as GVHD prophylaxis had been overrepresented in the no-GVHD group. In a multivariate analysis adjusted for age group, disease status, donor supply, and HLA match, a high ST2 concentration on time 14 was significantly associated with an increased risk of death without relapse within 6 months after transplantation for all conditioning regimens.